Hainan Shuangcheng Pharmaceuticals: Legal Opinion of Zhong Lun Law Firm on the First Extraordinary General Meeting of Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s Shareholders in 2024.

SZSI · Jul 16

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.